Memorial Park's land bridges are currently under construction. Rendering courtesy of Nelson Byrd Woltz

As Houstonians have been witnessing for the past few years, Memorial Park is in the midst of a renaissance, with a game-changing land bridge in the works, the recently opened Eastern Glades, and more than $200 million in improvements slated by 2028.

Now, Houston's crown green space has received another impressive donation towards the reintroduction of the native Gulf Coast prairie, courtesy of a $10 million contribution from the The Cyvia and Melvyn Wolff Family Foundation. The massive contribution will help the park's Land Bridge and Prairie project realize its innovative goals of establishing a more resilient ecology, enhancing animal habitats, improving storm water management, and providing a beautiful, immersive and accessible experience for Park visitors, according to a press release.

"The transformation of Memorial Park is vitally important to our city and our Foundation. We are honored to be part of this incredible effort and proud to join the Kinders and others who have funded the vision for the park," donor Cyvia Wolff said in a statement. "Together, we are creating one of the largest urban prairie reclamation efforts in Texas so that Houstonians can experience a native landscape that has largely been lost."

The multi-year project aims to restore 45 acres of native prairie to the park in an area that starts at the south basin of the land bridge and extends to an area north of Memorial Dr. For the time in more than a century, the land will look as it did when Indigenous people roamed the coastal plain — long before it was farmed by European settlers or served as the ground of Camp Logan, a training area for soldiers during World War I.

Once a dominant feature of coastal Texas and Louisiana, less than 1-percent of its historic range remains, according to the Memorial Park Conservancy. Seeds from plants found along the park's railroad tracks will be added to others collected by the Nature Conservancy to enable the project's realization.

One of the project's primary benefits will be making the park more resilient during floods. The new, south prairie basin will retain more water than the parking lots, woods, and baseball fields that occupied the area previously, while the prairie's deep root system will absorb more water that would otherwise wind up overwhelming Buffalo Bayou.

Increased biodiversity means that native species will return to the park for the first time. Its proximity to the park's Bayou Wilds forest should create more opportunities for bird watchers. Park visitors will be able to experience the prairie through trails and other paths that will connect to other areas of the park.

"Cyvia and Melvyn Wolff are an important part of the fabric of Houston with their leadership in business and education. It is a true honor for us to be working with the Wolff Foundation in returning to the park's ecological and cultural roots and to, quite literally, plant the seeds for Memorial Park's future," said Shellye Arnold, president and CEO of Memorial Park Conservancy. "Through thoughtful research, design, planting, and stewardship, this project will create new places for park visitors to enjoy, grow, and learn for years to come."

---

Steven Devadanam contributed to this article. This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.